| Nevada | |||||||||||
| (State or Other Jurisdiction of Incorporation) | |||||||||||
| 001-33245 | 04-3850065 | ||||||||||
| (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||
| 5340 Kietzke Lane, Suite 202 | |||||||||||
| Reno, | Nevada | ||||||||||
| (Address of Principal Executive Offices) | |||||||||||
| 89511 | |||||||||||
| (Zip Code) | |||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| Common Stock, $0.01 par value per share | EIG | New York Stock Exchange | ||||||||||||
|
EMPLOYERS HOLDINGS, INC. |
||||||||
| Dated: | April 29, 2026 |
/s/ Michael A. Pedraja |
||||||
Michael A. Pedraja |
||||||||
| Executive Vice President, | ||||||||
| Chief Financial Officer | ||||||||
| Exhibit No. | Exhibit | |||||||
| 99.1 | April 29, 2026 |
|||||||
| 99.2 | April 29, 2026 |
|||||||
Exhibit 99.1
| Page | ||||||||
| Consolidated Financial Highlights | ||||||||
| Summary Consolidated Balance Sheets | ||||||||
| Summary Consolidated Income Statements | ||||||||
Return on Equity |
||||||||
Combined Ratios |
||||||||
| Roll-forward of Unpaid Losses and LAE | ||||||||
| Consolidated Investment Portfolio | ||||||||
| Book Value Per Share | ||||||||
| Earnings Per Share | ||||||||
| Non-GAAP Financial Measures | ||||||||
Three Months Ended |
||||||||||||||||||||
| March 31, | ||||||||||||||||||||
| 2026 | 2025 | % change | ||||||||||||||||||
| Selected financial highlights: | ||||||||||||||||||||
| Gross premiums written | $ | 180.8 | $ | 212.1 | (15) | % | ||||||||||||||
| Net premiums written | 179.4 | 210.3 | (15) | |||||||||||||||||
| Net premiums earned | 180.9 | 183.0 | (1) | |||||||||||||||||
| Net investment income | 28.3 | 32.1 | (12) | |||||||||||||||||
Net income excluding LPT(1) |
9.0 | 11.2 | (20) | |||||||||||||||||
Adjusted net income(1) |
10.3 | 21.3 | (52) | |||||||||||||||||
| Net income before income taxes | 12.8 | 15.9 | (19) | |||||||||||||||||
| Net income | 10.2 | 12.8 | (20) | |||||||||||||||||
Comprehensive (loss) income |
(6.1) | 34.6 | (118) | |||||||||||||||||
| Total assets | 3,436.5 | 3,556.9 | (3) | |||||||||||||||||
| Stockholders' equity | 866.5 | 1,075.7 | (19) | |||||||||||||||||
Stockholders' equity including the Deferred Gain(2) |
953.3 | 1,168.1 | (18) | |||||||||||||||||
Adjusted stockholders' equity(2) |
962.3 | 1,228.8 | (22) | |||||||||||||||||
Trailing twelve months adjusted return on stockholders' equity(3) |
1.0 | % | 8.0 | % | (88) | % | ||||||||||||||
| Amounts per share: | ||||||||||||||||||||
| Cash dividends declared per share | $ | 0.32 | $ | 0.30 | 7 | % | ||||||||||||||
Earnings per diluted share(4) |
0.52 | 0.52 | — | |||||||||||||||||
Earnings per diluted share excluding LPT(4) |
0.46 | 0.46 | — | |||||||||||||||||
Adjusted earnings per diluted share(4) |
0.53 | 0.87 | (39) | |||||||||||||||||
Book value per share(2) |
46.59 | 44.43 | 5 | |||||||||||||||||
Book value per share including the Deferred Gain(2) |
51.26 | 48.25 | 6 | |||||||||||||||||
Adjusted book value per share(2) |
51.75 | 50.75 | 2 | |||||||||||||||||
Combined ratio excluding LPT:(5): |
||||||||||||||||||||
Loss and loss adjustment expense ratio: |
||||||||||||||||||||
Current Year |
72.1 | % | 66.1 | % | ||||||||||||||||
Prior Year |
(0.1) | 0.7 | ||||||||||||||||||
Loss and loss adjustment expense ratio |
72.0 | % | 66.8 | % | ||||||||||||||||
Commission expense ratio |
13.1 | % | 12.6 | % | ||||||||||||||||
| Underwriting expense ratio | 22.6 | % | 23.4 | % | ||||||||||||||||
Combined ratio excluding LPT |
107.7 | % | 102.8 | % | ||||||||||||||||
| (1) See Page 3 for calculations and Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||||||||
(2) See Page 8 for calculations and Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||||||||
| (3) See Page 4 for calculations and Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||||||||
| (4) See Page 9 for description and calculations and Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||||||||
| (5) See Pages 5 for details and Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||||||||
| March 31, 2026 |
December 31, 2025 |
|||||||||||||
| ASSETS | ||||||||||||||
| Investments, cash and cash equivalents | $ | 2,488.2 | $ | 2,498.8 | ||||||||||
| Accrued investment income | 15.0 | 15.5 | ||||||||||||
Premiums receivable, net |
337.4 | 335.4 | ||||||||||||
| Reinsurance recoverable, net of allowance, on paid and unpaid losses and LAE | 387.7 | 391.6 | ||||||||||||
| Deferred policy acquisition costs | 57.1 | 57.1 | ||||||||||||
| Deferred income tax asset, net | 18.8 | 14.3 | ||||||||||||
| Other assets | 132.3 | 123.9 | ||||||||||||
| Total assets | $ | 3,436.5 | $ | 3,436.6 | ||||||||||
| LIABILITIES | ||||||||||||||
| Unpaid losses and LAE | $ | 1,802.5 | $ | 1,805.8 | ||||||||||
| Unearned premiums | 392.7 | 391.9 | ||||||||||||
| Commissions and premium taxes payable | 55.2 | 59.9 | ||||||||||||
| Deferred Gain | 86.8 | 88.0 | ||||||||||||
| Debt | 125.0 | 35.0 | ||||||||||||
| Other liabilities | 107.8 | 100.3 | ||||||||||||
| Total liabilities | $ | 2,570.0 | $ | 2,480.9 | ||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||
| Common stock and additional paid-in capital | $ | 429.1 | $ | 428.4 | ||||||||||
| Retained earnings | 1,457.8 | 1,453.8 | ||||||||||||
Accumulated other comprehensive (loss) income |
(9.0) | 7.3 | ||||||||||||
Treasury stock, at cost |
(1,011.4) | (933.8) | ||||||||||||
| Total stockholders’ equity | 866.5 | 955.7 | ||||||||||||
| Total liabilities and stockholders’ equity | $ | 3,436.5 | $ | 3,436.6 | ||||||||||
Stockholders' equity including the Deferred Gain (1) |
$ | 953.3 | $ | 1,043.7 | ||||||||||
Adjusted stockholders' equity (1) |
962.3 | 1,036.4 | ||||||||||||
Book value per share (1) |
$ | 46.59 | $ | 46.98 | ||||||||||
Book value per share including the Deferred Gain(1) |
51.26 | 51.31 | ||||||||||||
Adjusted book value per share (1) |
51.75 | 50.95 | ||||||||||||
(1) See Page 8 for calculations and Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||
| Three Months Ended | |||||||||||
| March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Revenues: | |||||||||||
| Net premiums earned | $ | 180.9 | $ | 183.0 | |||||||
| Net investment income | 28.3 | 32.1 | |||||||||
Net realized and unrealized losses on investments(1) |
(1.7) | (12.8) | |||||||||
| Other income | 0.1 | 0.3 | |||||||||
| Total revenues | 207.6 | 202.6 | |||||||||
| Expenses: | |||||||||||
| Losses and LAE incurred | (129.1) | (120.7) | |||||||||
| Commission expense | (23.7) | (23.0) | |||||||||
| Underwriting expenses | (40.9) | (42.9) | |||||||||
| Interest and financing expenses | (1.1) | (0.1) | |||||||||
| Total expenses | (194.8) | (186.7) | |||||||||
Net income before income taxes |
12.8 | 15.9 | |||||||||
Income tax expense |
(2.6) | (3.1) | |||||||||
| Net Income | 10.2 | 12.8 | |||||||||
Unrealized AFS investment (losses) gains arising during the period, net of tax(2) |
(16.7) | 21.1 | |||||||||
Reclassification adjustment for net realized AFS investment losses in net income, net of tax(2) |
0.4 | 0.7 | |||||||||
Total comprehensive (loss) income |
$ | (6.1) | $ | 34.6 | |||||||
| Net Income | $ | 10.2 | $ | 12.8 | |||||||
| Amortization of the Deferred Gain - losses | (1.2) | (1.6) | |||||||||
Net income excluding LPT Agreement (3) |
9.0 | 11.2 | |||||||||
Net realized and unrealized losses on investments |
1.7 | 12.8 | |||||||||
Income tax benefit related to items excluded from Net income |
(0.4) | (2.7) | |||||||||
Adjusted net income |
$ | 10.3 | $ | 21.3 | |||||||
(1) Includes unrealized (losses) on equity securities and other investments of $(2.7) million and $(11.7) million for the three months ended March 31, 2026 and 2025, respectively. | |||||||||||
| (2) AFS = Available for Sale securities. | |||||||||||
(3) See Page 10 regarding our use of Non-GAAP Financial Measures. |
|||||||||||
| Three Months Ended | ||||||||||||||
| March 31, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
Net income |
A | $ | 10.2 | $ | 12.8 | |||||||||
| Impact of the LPT Agreement | (1.2) | (1.6) | ||||||||||||
Net realized and unrealized losses on investments |
1.7 | 12.8 | ||||||||||||
Income tax benefit related to items excluded from Net income |
(0.4) | (2.7) | ||||||||||||
Adjusted net income(1) |
B | 10.3 | 21.3 | |||||||||||
| Stockholders' equity - end of period | $ | 866.5 | $ | 1,075.7 | ||||||||||
| Stockholders' equity - beginning of period | 955.7 | 1,068.7 | ||||||||||||
| Average stockholders' equity | C | 911.1 | 1,072.2 | |||||||||||
| Stockholders' equity - end of period | $ | 866.5 | $ | 1,075.7 | ||||||||||
| Deferred Gain - end of period | 86.8 | 92.4 | ||||||||||||
| Accumulated other comprehensive loss - end of period | 11.4 | 76.8 | ||||||||||||
| Income taxes related to accumulated other comprehensive loss - end of period | (2.4) | (16.1) | ||||||||||||
| Adjusted stockholders' equity - end of period | 962.3 | 1,228.8 | ||||||||||||
| Adjusted stockholders' equity - beginning of period | 1,036.4 | 1,245.2 | ||||||||||||
Average adjusted stockholders' equity (1) |
D | 999.4 | 1,237.0 | |||||||||||
| Return on stockholders' equity | A / C | 1.1 | % | 1.2 | % | |||||||||
Trailing twelve months return on stockholders' equity |
0.8 | 9.8 | ||||||||||||
Adjusted return on stockholders' equity (1) |
B / D | 1.0 | % | 1.7 | % | |||||||||
Trailing twelve months adjusted return on stockholders' equity (1) |
1.0 | 8.0 | ||||||||||||
(1) See Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||
| Three Months Ended | ||||||||||||||
| March 31, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
Net premiums earned |
A | $ | 180.9 | $ | 183.0 | |||||||||
Losses and LAE incurred |
B | 129.1 | 120.7 | |||||||||||
Amortization of deferred reinsurance gain - losses |
1.2 | 1.6 | ||||||||||||
Losses and LAE excluding LPT(1) |
C | 130.3 | 122.3 | |||||||||||
| Prior year loss reserve development | (0.1) | 1.3 | ||||||||||||
Losses and LAE excluding LPT - current accident year |
D | $ | 130.4 | $ | 121.0 | |||||||||
Commission expense |
E | $ | 23.7 | $ | 23.0 | |||||||||
| Underwriting expenses | F | $ | 40.9 | $ | 42.9 | |||||||||
GAAP combined ratio: |
||||||||||||||
Loss and LAE ratio |
B/A |
71.4 | % | 66.0 | % | |||||||||
Commission expense ratio |
E/A |
13.1 | 12.6 | |||||||||||
| Underwriting expense ratio | F/A |
22.6 | 23.4 | |||||||||||
GAAP combined ratio |
107.1 | % | 102.0 | % | ||||||||||
Combined ratio excluding LPT:(1) |
||||||||||||||
Loss and LAE ratio excluding LPT |
C/A |
72.0 | % | 66.8 | % | |||||||||
Commission expense ratio |
E/A |
13.1 | 12.6 | |||||||||||
| Underwriting expense ratio | F/A |
22.6 | 23.4 | |||||||||||
Combined ratio excluding LPT |
107.7 | % | 102.8 | % | ||||||||||
Combined ratio excluding LPT: current accident year:(1) |
||||||||||||||
Loss and LAE ratio excluding LPT |
D/A |
72.1 | % | 66.1 | % | |||||||||
Commission expense ratio |
E/A |
13.1 | 12.6 | |||||||||||
| Underwriting expense ratio | F/A |
22.6 | 23.4 | |||||||||||
Combined ratio excluding LPT: current accident year |
107.8 | % | 102.1 | % | ||||||||||
(1) See Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||
| Three Months Ended | |||||||||||
| March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Unpaid losses and LAE at beginning of period | $ | 1,805.8 | $ | 1,808.2 | |||||||
| Reinsurance recoverable, excluding CECL allowance, on unpaid losses and LAE | 386.5 | 412.4 | |||||||||
| Net unpaid losses and LAE at beginning of period | 1,419.3 | 1,395.8 | |||||||||
| Losses and LAE incurred: | |||||||||||
| Current year losses | 130.5 | 121.0 | |||||||||
Prior year losses on voluntary business |
— | 0.7 | |||||||||
| Prior year losses on involuntary business | (0.1) | 0.6 | |||||||||
| Total losses incurred | 130.4 | 122.3 | |||||||||
| Losses and LAE paid: | |||||||||||
| Current year losses | 6.4 | 8.0 | |||||||||
| Prior year losses | 123.9 | 124.6 | |||||||||
| Total paid losses | 130.3 | 132.6 | |||||||||
| Net unpaid losses and LAE at end of period | 1,419.4 | 1,385.5 | |||||||||
| Reinsurance recoverable, excluding CECL allowance, on unpaid losses and LAE | 383.1 | 407.1 | |||||||||
| Unpaid losses and LAE at end of period | $ | 1,802.5 | $ | 1,792.6 | |||||||
| March 31, 2026 | December 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Investment Positions: |
Cost or Amortized
Cost (1)
|
Net Unrealized Gain (Loss) | Fair Value | % | Fair Value | % | ||||||||||||||||||||||||||||||||
| Fixed maturity securities | $ | 2,045.8 | $ | (11.4) | $ | 2,033.7 | 82 | % | $ | 2,040.7 | 82 | % | ||||||||||||||||||||||||||
| Equity securities | 106.1 | 84.7 | 190.8 | 8 | 191.5 | 8 | ||||||||||||||||||||||||||||||||
| Short-term investments | 14.6 | — | 14.6 | 1 | 10.1 | — | ||||||||||||||||||||||||||||||||
| Other invested assets | 78.5 | 17.3 | 95.8 | 4 | 96.5 | 4 | ||||||||||||||||||||||||||||||||
| Cash and cash equivalents | 153.1 | — | 153.1 | 6 | 159.8 | 6 | ||||||||||||||||||||||||||||||||
| Restricted cash and cash equivalents | 0.2 | — | 0.2 | — | 0.2 | — | ||||||||||||||||||||||||||||||||
| Total investments and cash | $ | 2,398.3 | $ | 90.6 | $ | 2,488.2 | 100 | % | $ | 2,498.8 | 100 | % | ||||||||||||||||||||||||||
| Breakout of Fixed Maturity Securities: | ||||||||||||||||||||||||||||||||||||||
| U.S. Treasuries and agencies | $ | 81.3 | $ | (0.3) | $ | 81.0 | 4 | % | $ | 80.1 | 4 | % | ||||||||||||||||||||||||||
| States and municipalities | 144.0 | 1.7 | 145.7 | 7 | 159.9 | 8 | ||||||||||||||||||||||||||||||||
| Corporate securities | 706.1 | (9.4) | 696.7 | 34 | 655.3 | 32 | ||||||||||||||||||||||||||||||||
| Mortgage-backed securities | 803.5 | (2.9) | 800.6 | 39 | 831.8 | 41 | ||||||||||||||||||||||||||||||||
| Asset-backed securities | 153.1 | 0.9 | 154.0 | 8 | 163.1 | 8 | ||||||||||||||||||||||||||||||||
| Collateralized loan obligations | 2.5 | — | 2.5 | — | 12.5 | 1 | ||||||||||||||||||||||||||||||||
| Bank loans and other | 155.3 | (1.4) | 153.2 | 8 | 138.0 | 7 | ||||||||||||||||||||||||||||||||
| Total fixed maturity securities | $ | 2,045.8 | $ | (11.4) | $ | 2,033.7 | 100 | % | $ | 2,040.7 | 100 | % | ||||||||||||||||||||||||||
| Weighted average book yield | 4.9% | 4.9% | |||||||||||||||||||||
| Average credit quality (S&P) | A+ | A+ | |||||||||||||||||||||
Duration(2) |
4.4 | 4.4 | |||||||||||||||||||||
(1) Amortized cost excludes allowance for current expected credit losses of $0.7 million |
|||||||||||||||||||||||
(2) Duration is measured by the sensitivity to changes in interest rates |
|||||||||||||||||||||||
| March 31, 2026 |
December 31, 2025 |
March 31, 2025 |
December 31, 2024 |
||||||||||||||||||||
| Numerators: | |||||||||||||||||||||||
| Stockholders' equity | A | $ | 866.5 | $ | 955.7 | $ | 1,075.7 | $ | 1,068.7 | ||||||||||||||
| Plus: Deferred Gain | 86.8 | 88.0 | 92.4 | 94.0 | |||||||||||||||||||
Stockholders' equity including the Deferred Gain (1) |
B | 953.3 | 1,043.7 | 1,168.1 | 1,162.7 | ||||||||||||||||||
Accumulated other comprehensive loss (income) |
11.4 | (9.3) | 76.8 | 104.5 | |||||||||||||||||||
Income taxes related to accumulated other comprehensive (loss) income |
(2.4) | 2.0 | (16.1) | (22.0) | |||||||||||||||||||
Adjusted stockholders' equity (1) |
C | $ | 962.3 | $ | 1,036.4 | $ | 1,228.8 | $ | 1,245.2 | ||||||||||||||
| Denominator (shares outstanding) | D | 18,596,468 | 20,342,135 | 24,210,602 | 24,556,706 | ||||||||||||||||||
Book value per share (1) |
A / D | $ | 46.59 | $ | 46.98 | $ | 44.43 | $ | 43.52 | ||||||||||||||
Book value per share including the Deferred Gain(1) |
B / D | 51.26 | 51.31 | 48.25 | 47.35 | ||||||||||||||||||
Adjusted book value per share (1) |
C / D | 51.75 | 50.95 | 50.75 | 50.71 | ||||||||||||||||||
Year-over-year change in: (2) |
|||||||||||||||||||||||
| Book value per share | 7.7 | % | 10.8 | % | 13.5 | % | 11.9 | % | |||||||||||||||
| Book value per share including the Deferred Gain | 8.9 | 11.0 | 12.3 | 10.6 | |||||||||||||||||||
| Adjusted book value per share | 4.5 | 3.0 | 8.5 | 9.8 | |||||||||||||||||||
(1) See Page 10 for information regarding our use of Non-GAAP Financial Measures. | |||||||||||||||||||||||
(2) Reflects the twelve month change in book value per share after taking into account dividends declared of $1.28, $1.26, $1.20, and $1.18 for the twelve month periods ended March 31, 2026, December 31, 2025, December 31, 2024 and March 31, 2025, respectively. | |||||||||||||||||||||||
| Three Months Ended | ||||||||||||||
| March 31, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
| Numerators: | ||||||||||||||
Net income |
A | $ | 10.2 | $ | 12.8 | |||||||||
| Impact of the LPT Agreement | (1.2) | (1.6) | ||||||||||||
Net income excluding LPT (1) |
B | 9.0 | 11.2 | |||||||||||
Net realized and unrealized losses on investments |
1.7 | 12.8 | ||||||||||||
Income tax benefit related to items excluded from Net income |
(0.4) | (2.7) | ||||||||||||
Adjusted net income(1) |
C | $ | 10.3 | $ | 21.3 | |||||||||
| Denominators: | ||||||||||||||
| Average common shares outstanding (basic) | D | 19,359,261 | 24,398,610 | |||||||||||
| Average common shares outstanding (diluted) | E | 19,505,827 | 24,606,572 | |||||||||||
Earnings per share: |
||||||||||||||
| Basic | A / D | $ | 0.53 | $ | 0.52 | |||||||||
Diluted |
A / E | 0.52 | 0.52 | |||||||||||
Earnings per share excluding LPT: (1) |
||||||||||||||
| Basic | B / D | $ | 0.46 | $ | 0.46 | |||||||||
Diluted |
B / E | 0.46 | 0.46 | |||||||||||
Adjusted earnings per share: (1) |
||||||||||||||
| Basic | C / D | $ | 0.53 | $ | 0.87 | |||||||||
| Diluted | C / E | 0.53 | 0.87 | |||||||||||
(1) See Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||